Tech Company Financing Transactions
Avidimer Therapeutics Funding Round
On 9/30/2007, Avidimer Therapeutics raised $2.5 million in funding from Flagship Pioneering and North Coast Technology Investors.
Transaction Overview
Company Name
Announced On
9/30/2007
Transaction Type
Venture Equity
Amount
$2,514,000
Round
Undisclosed
Investors
Flagship Pioneering (James Matheson)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
130 W. Chicago Blvd.
Tecumseh, MI 49286
USA
Tecumseh, MI 49286
USA
Phone
Website
Email Address
Overview
Avidimer Therapeutics develops and commercializes pharmaceuticals, called avidimers, based on proprietary nanotechnology. Avidimers are 'smart drugs' designed to maximize damage to disease targets while minimizing collateral damage to healthy tissue. The initial focus of the company is on cancer detection and treatment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Larry Sternson
Chief Scientific Officer
James Baker
VP - Bus. Development
David Repp
VP - Regulatory Affairs
Deborah Ladenheim
Browse more venture capital transactions:
Prev: 9/30/2007: Infectious.com venture capital transaction
Next: 9/30/2007: InTouch Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs